Copyright
©2014 Baishideng Publishing Group Inc.
World J Hematol. Aug 6, 2014; 3(3): 85-92
Published online Aug 6, 2014. doi: 10.5315/wjh.v3.i3.85
Published online Aug 6, 2014. doi: 10.5315/wjh.v3.i3.85
Parameter | Scores | |
IPSS | DIPSS | |
Age > 65 yr | 1 | 1 |
Hemoglobin < 10 g/dL | 1 | 2 |
Leukocyte count > 25 × 109/L | 1 | 1 |
Blast cells ≥ 1% | 1 | 1 |
Constitutional symptoms | 1 | 1 |
Parameter | Score value |
DIPSS intermediate-1 | 1 |
DIPSS intermediate-2 | 2 |
DIPSS high risk | 3 |
Unfavorable cytogenetics | 1 |
Red blood cell need | 1 |
Platelet < 100 ×109/L | 1 |
- Citation: Maffioli M, Caramazza D, Mora B, Merli M, Passamonti F. Myelofibrosis: Prognostication and cytoreductive treatment. World J Hematol 2014; 3(3): 85-92
- URL: https://www.wjgnet.com/2218-6204/full/v3/i3/85.htm
- DOI: https://dx.doi.org/10.5315/wjh.v3.i3.85